The Journal of Organic Chemistry
Article
150.2, 140.4, 138.7, 138.5, 138.4, 136.0, 135.5, 135.4, 128.4, 122.0,
116.5, 115.7, 73.3, 72.9, 69.7, 69.6, 66.4, 66.3, 30.9, 29.7, 15.3. ES-MS:
m/z 780.3 (M + Na)+, 758.3 (M + H)+. Anal. Calcd for C44H59N3O8:
C, 69.72; H, 7.85; N, 5.54. Found: C, 69.64; H, 7.97; N, 5.65.
5,11-Bis[(N,N′-di-Boc)guanidine]-25,26,27,28-tetrakis(2-
ethoxyethoxy)calix[4]arene (15). A stirring solution of the 1,2-
vicinal diaminocalix[4]arene 11 (0.1 g, 0.135 mmol) and bis-Boc
thiourea (0.088 g, 0.314 mmol) in dry DMF (6 mL) was cooled to
0 °C with an ice-bath and then Et3N (0.131 mL, 0.94 mmol) and
HgCl2 (0.085 g, 0.314 mmol) were added. After 2 h, the reaction was
quenched by adding AcOEt (15 mL) and filtering the HgS precipitate.
The solvents were removed from the collected filtrate at the rotavapor
and the resulting reddish foam chromatographed (SiO2; hexane/
AcOEt, 3:1). Compound 15 was obtained as a white solid (0.089 g;
with H2O (15 mL). The organic phase was separated and dried over
Na2SO4 and the filtrate evaporated under reduced pressure. The
residue was recrystallized from Et2O/hexane to obtain pure compound
18 (0.44 g; 59% yield): mp > 300 °C. 1H NMR (400 MHz, CDCl3): δ
11.59 (s, 4H), 9.83 (s, 4H), 6.94 (s, 8H), 4.46 (d, J = 13 Hz, 4H), 4.09
(t, J = 5.6 Hz, 8H), 3.83 (t, J = 5.6 Hz, 8H), 3.53 (q, J = 7 Hz, 8H),
3.15 (d, J = 13 Hz, 4H), 1.47 and 1.44 (2s, 36H each), 1.20 (t, J = 7
Hz, 12H). 13C NMR (100 MHz, CDCl3): δ 163.6, 153.6, 153.0, 134.7,
131.0, 123.2, 83.0, 79.1, 73.3, 69.4, 66.4, 31.2, 28.2, 28.1, 15.3. ES-MS:
m/z 893.46 (M + 2Na)2+/2, 1763.85 (M + Na)+.
5,11-Diguanidine-25,26,27,28-tetrakis(2-ethoxyethoxy)-
calix[4]arene Bis-hydrochloride (1·2HCl). To a stirring solution of
the 1,2-vicinal derivative 15 (0.083 g, 0.068 mmol) in 1,4-dioxane (6.8
mL), 37% HCl (0.23 mL, 2.76 mmol) was added. After 5 days at room
temperature, the solvent was removed at the rotavapor; pure
compound 1·2HCl was obtained in quantitative yield as a white solid
(0.061 g; 99% yield): mp 136−139 °C. 1H NMR (300 MHz, CD3OD) δ
6.78−6.60 (m, 10H), 4.62 (d, J = 13.5 Hz, 1H), 4.60 (d, J = 13.5 Hz,
2H), 4.57 (d, J = 13.5 Hz, 1H), 4.28−4.09 (m, 8H), 4.00−3.82 (m,
8H), 3.62 and 3.57 (2q, J = 7.0 Hz, 4H each), 3.25 (d, J = 13.5 Hz,
1H), 3.23 (d, J = 13.5 Hz, 2H), 3.20 (d, J = 13.5 Hz, 1H), 1.22 and
1.21 (2t, J = 7.0 Hz, 6H each). 13C NMR (100 MHz, CDCl3): δ 156.5,
156.3, 156.0, 137.3, 136.4, 135.3, 134.4, 128.3, 127.9, 125.5, 125.0,
122.3, 73.8, 73.3, 70.0, 69.7, 66.2, 66.0, 30.4, 30.3, 14.3, 14.2. ES-MS:
m/z 849.32 (1 + Na)+, 827.35 (1 + H)+: HR ES-MS: m/z Calcd for
1
54% yield): mp 104−106 °C. H NMR (300 MHz, CDCl3) δ 11.58
(s, 2H), 9.79 (s, 2H), 6.74 (s, 2H), 6.73 (s, 2H), 6.62 (s, 6H), 4.49 (d,
J = 12.8 Hz, 1H), 4.45 (d, J = 12.8 Hz, 2H), 4.41 (d, J = 12.8 Hz, 1H),
4.08 and 4.04 (2t, J = 6.1 Hz, 4H each), 3.81 and 3.79 (2t, J = 6.1 Hz,
4H each), 3.53 (q, J = 7.2 Hz, 8H), 3.14 (d, J = 12.8 Hz, 1H), 3.13 (d,
J = 12.8 Hz, 3H), 1.51 and 1.47 (2s, 18H each), 1.25−1.12 (m, 12H).
13C NMR (100 MHz, CDCl3): δ 163.6, 156.5, 153.9, 153.4, 153.2,
135.4, 135.1, 134.8, 130.6, 128.3, 122.7, 122.6, 122.1, 83.3, 79.2, 73.1,
69.7, 69.4, 66.4, 30.9, 28.2, 28.1, 15.3. ES-MS: m/z 1249.5 (M + Na)+,
1227.7 (M + H)+. Anal. Calcd for C66H94N6O16: C, 64.58; H, 7.72; N,
6.85. Found: C, 64.63; H, 7.81; N, 6.95.
5,17-Bis[(N,N′-di-Boc)guanidine]-25,26,27,28-tetrakis(2-
ethoxyethoxy)calix[4]arene (16). The reaction was carried out as
for the preparation of compound 15, starting from 1,3-distal
diaminocalix[4]arene 12 (0.12 g, 0.16 mmol). A pure sample of 16
was obtained by flash column chromatography (SiO2, cyclohexane/
AcOEt, 15:4) as a white solid (0.086 g; 45% yield): mp 157−160 °C.
1H NMR (300 MHz, CDCl3): δ 11.65 (s, 2H), 10.24 (s, 2H), 7.29 (s,
4H), 6.32−6.19 (m, 6H), 4.45 (d, J = 13.2 Hz, 4H), 4.24 (t, J = 6.6 Hz,
4H), 3.95−3.81 (m, 8H), 3.76 (t, J = 5.0 Hz, 4H), 3.56 and 3.51 (2q,
J = 7.2 Hz, 4H each), 3.12 (d, J = 13.2 Hz, 4H), 1.54 and 1.49 (2s,
18H each), 1.23 and 1.18 (2t, J = 7.2 Hz, 6H each). 13C NMR (100
MHz, CDCl3): δ 163.7, 155.0, 154.7, 153.4, 153.3, 136.9, 133.0, 130.7,
127.8, 122.6, 122.4, 83.5, 79.4, 73.9, 72.5, 69.6, 69.5, 66.5, 66.2, 30.8,
28.2, 28.1, 15.4, 15.3. ES-MS: m/z 1227.6 (M + H)+. Anal. Calcd (%)
for C66H94N6O16: C, 64.58; H, 7.72; N, 6.85. Found: C, 64.51; H,
7.83; N, 6.93.
+
C46H63N6O8 827.4707 (1 + H)+, found 827.4693.
5,17-Diguanidine-25,26,27,28-tetrakis(2-ethoxyethoxy)-
calix[4]arene Bis-hydrochloride (2·2HCl). The reaction was carried
out according to the preparation of compound 1, stirring for 4 days a
mixture of compound 16 (0.086 g, 0.07 mmol), 0.23 mL of 37% HCl
(2.76 mmol), and 5 mL of 1,4-dioxane. Compound 2·2HCl was
obtained in quantitative yield as a pale-yellow oil (0.077 g; 99% yield).
1H NMR (400 MHz, CD3OD) δ 7.00 (d, J = 7.2 Hz, 4H), 6.83 (t, J =
7.2 Hz, 2H), 6.42 (s, 4H), 4.62 (d, J = 13.0 Hz, 4H), 4.33 (t, J = 6.0
Hz, 4H), 4.09 (t, J = 5.0 Hz, 4H), 3.97 (t, J = 6.0 Hz, 4H), 3.91 (t, J =
5.0 Hz, 4H), 3.64 and 3.57 (2q, J = 7.0 Hz, 4H each), 3.25 (d, J = 13.0
Hz, 4H), 1.27 and 1.20 (2t, J = 7.0 Hz, 6H each).13C NMR (75 MHz,
CD3OD): δ 158.2, 157.8, 156.5, 137.7, 136.7, 130.0, 129.5, 126.1,
124.0, 75.4, 74.2, 71.2, 67.6, 67.3, 31.8, 15.72, 15.68. ES-MS: m/z 414.1
[(2 + 2H)2+]/2, 827.4 (2 + H)+; HR ES-MS m/z Calcd for C46H63N6O8+
827.4707 (2 + H)+, found 827.4738.
5,11,17-Triguanidine-25,26,27,28-tetrakis(2-ethoxyethoxy)-
calix[4]arene Tris-hydrochloride (3·3HCl). The reaction was
carried out according to the preparation of compound 1, stirring for
4 days a mixture of the trifunctional derivative 17 (0.1 g, 0.068 mmol),
37% HCl (0.335 mL, 4.0 mmol), and 6.7 mL of 1,4-dioxane. The
reaction was quenched, removing the solvent at the rotavapor, and
pure compound 3·3HCl was obtained in quantitative yield as a pale-
yellow oil (0.077 g; 99% yield). 1H NMR (400 MHz, CD3OD): δ 6.83
(d, J = 7.2 Hz, 2H), 6.79−6.71 (m, 3H), 6.55 (s, 4H), 4.61 and 4.58
(2d, J = 13.3 Hz, 2H each), 4.25 (t, J = 3.9 Hz, 2H), 4.19 (t, J = 5.1 Hz,
2H), 4.20−4.05 (m, 4H), 3.99−3.81 (m, 8H), 3.72−3.50 (m, 8H),
3.26 and 3.23 (2d, J = 13.3 Hz, 2H each), 1.26−1.11 (m, 12H). 13C
NMR (75 MHz, CD3OD) δ: 157.87, 157.82, 157.76, 157.58, 156.9,
138.1, 138.0, 137.3, 136.1, 129.7, 127.0, 126.6, 126.2, 124.0, 75.3, 75.1,
74.5, 71.4, 71.3, 71.0, 67.6, 67.4, 31.8, 31.7, 15.72, 15.68. ES-MS: m/z
442.8 [(3 + 2H)2+]/2, 295.6 [(3 + 3H)3+]/3. HR ES-MS m/z Calcd
5,11,17-Tris[(N,N′-di-Boc)guanidine]-25,26,27,28-tetrakis(2-
ethoxyethoxy)calix[4]arene (17). The reaction was carried out
according to the preparation of compound 15, starting from triamino
compound 13 (0.147 g, 0.194 mmol), 3 equiv of bis-Boc-thiourea and
HgCl2 and 9 equiv of Et3N. A pure sample of 17 was obtained by flash
column chromatography (SiO2; hexane/AcOEt, 3:1) as a slightly pink
1
oil (0.145 g; 50% yield). H NMR (300 MHz, CDCl3): δ 11.67 (bs,
2H), 11.55 (bs, 1H), 10.27 (bs, 2H), 9.31 (bs, 1H), 7.33 and 7.28 (2d,
2H each, J = 2.3 Hz), 6.37 (t, 1H, J = 7.6 Hz), 6.22 (d, 2H, J = 7.6 Hz),
6.17 (s, 2H), 4.45 and 4.41 (2d, J = 13.5 Hz, 2H each), 4.20 (t, J = 5.9
Hz, 4H), 3.60−3.47 (m, 12H), 3.60−3.46 (m, 8H), 3.13 and 3.11 (2d,
J = 13.5 Hz, 2H each), 1.53, 1.49, 1.47, and 1.42 (4s, 54H), 1.22 and
1.16 (2t, J = 6.9 Hz, 6H each). 13C NMR (100 MHz, CDCl3): δ 163.6,
155.1, 154.9, 153.8, 153.4, 153.2, 153.0, 152.7, 136.9, 136.7, 133.6,
133.2, 130.8, 130.4, 127.8, 123.3, 122.5, 122.4, 122.1, 83.4, 83.1, 79.4,
79.0, 73.8, 72.5, 69.6, 69.5, 69.4, 66.6, 66.5, 66.2, 31.0, 28.2, 28.1, 15.4,
15.2. ES-MS: m/z 1484.6 (M + H)+, 1506.6 (M + Na)+. Anal. Calcd
for C77H113N9O20: C, 62.29; H, 7.67; N, 8.49. Found: C, 62.18; H,
7.73; N, 8.56.
5,11,17,23-Tetrakis[(N,N′-di-Boc)guanidine]-25,26,27,28-
tetrakis(2-ethoxyethoxy)calix[4]arene (18). The reaction was
carried out according to the preparation of compound 15, starting
from tetraamino compound 14 (0.650 g, 0.84 mmol), 4.5 equiv of bis-
Boc-thiourea and HgCl2 and 12 equiv of Et3N in dry DMF (30 mL).
After 18 h, DCM was added and HgS filtered off. After removal
of DCM at the rotavapor, the DMF solution was left standing,
and a white solid precipitated, was filtered off, and washed with
hexane. The solvents were completely removed from the filtrate at the
rotavapor, and the residue was uptaken in AcOEt (15 mL) and washed
2+
for C47H67N9O8 442.7556 [(3 + 2H)2+]/2, found 442.7570.
5,11,17,23-Tetraguanidine-25,26,27,28-tetrakis(2-
ethoxyethoxy)calix[4]arene Tetrakis-hydrochloride (4·4HCl).
To a stirring solution of compound 18 (0.425 g, 0.24 mmol) in 1,4-
dioxane (30 mL) at rt were added a 37% HCl aqueous solution (3.5
mL) and triethylsilane (TES) (0.39 mL, 2.44 mmol). After 24 h, the
solvent was evaporated and the residue dissolved in water and washed
with Et2O (2 × 10 mL). The aqueous layer was lyophilized, thus
leaving a sample of pure compound 4·4HCl (0.250 g; 96% yield):
mp > 300 °C. 1H NMR (300 MHz, D2O): δ 6.78 (s, 8H), 4.53 (d, J =
13.5, 4H), 4.25 (t, J = 4.5 Hz, 8H), 3.99 (t, J = 4.5 Hz, 8H), 3.66 (q,
J = 7 Hz, 8H), 3.37 (d, J = 13.5, 4H), 1.20 (t, J = 7 Hz, 12H). 13C
NMR (100 MHz, D2O/MeOD, 7/3): δ 156.8, 156.5, 137.2, 129.1,
3387
dx.doi.org/10.1021/jo300193y | J. Org. Chem. 2012, 77, 3381−3389